RecruitingPhase 3NCT06963021
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Sponsor: Neurocrine Biosciences
Charlotte, NC · +14 more sites
Depression clinical trials in Charlotte, NC
4 recruiting depression studies with a site in Charlotte, NC.
RecruitingPhase 3NCT06748222
E-Mindfulness Approaches for Living After Breast Cancer
Sponsor: NRG Oncology
Albemarle, NC · Asheboro, NC · Burlington, NC · +378 more sites
RecruitingPhase 3NCT07196501
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Sponsor: Neurocrine Biosciences
Charlotte, NC · +23 more sites
RecruitingPhase 2NCT07553637
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Sponsor: Alto Neuroscience
Charlotte, NC · +37 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.